Metrics
Publication
26
Open Access
3
UN Sustainable Development Goals
Education
2011 - 2016
2011 - 2016Doctorate
Istanbul University, Istanbul Medical Faculty, Basic Medical Sciences, Turkey
Research Areas
Health Sciences
Natural Sciences
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2009 - Present
2009 - PresentResearcher
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Articles
All (23)
SCI-E, SSCI, AHCI (21)
SCI-E, SSCI, AHCI, ESCI (22)
ESCI (1)
Scopus (22)
TRDizin (2)
2025
20251. UV-synthesized albumin-based doxorubicin nanoparticles induce apoptosis and modulate leukemia surface markers while overcoming drug resistance.
Danışman-Kalındemirtaş F., Sert E., Kariper I. A., Korkut I. N., Erdem-Kuruca S.
Naunyn-Schmiedeberg's archives of pharmacology
, 2025 (SCI-Expanded, Scopus)
2025
20252. Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation.
Abuaisha A., Nekay E., Yilmaz O., Yildiz B., Mecit T., Yavas C., et al.
Biology
, vol.14, no.10, 2025 (SCI-Expanded, Scopus)
2025
20253. Effects of Curcumin on Cancer Stem Cell Markers and P-Glycoprotein-Mediated Drug Resistance in U87 Glioblastoma Cells
NAZLIGÜL E., ÖZERMAN EDİS B., YENEREL M. N., GÜNÇER B.
Sabiad
, vol.8, no.3, pp.137-148, 2025 (Peer-Reviewed Journal)
2025
20254. Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis
Abuaisha A., Kaya M., Suer İ., Emiroglu S., Bayram A., Tukenmez M., et al.
MEDICINA-LITHUANIA
, vol.61, no.9, 2025 (SCI-Expanded, Scopus)
2025
20255. Synthesis, in-vitro, in-silico, and global DNA methylation studies of curcumin-benzoquinone analog in triple-negative breast cancer (TNBC) cells
GÜNÇER B., Ozkok F., Aldogan E. H., Oyaci Y., Nazligul E., Edis B., et al.
TOXICOLOGY RESEARCH
, vol.14, no.4, 2025 (SCI-Expanded)
2025
20256. In silico and in vitro investigation of anticancer effect of novel anthraquinone compound on MDA-MB-231 cells
Güler V., Şentürk A. M., Özerman Edis B., Bektaş N., Nazlıgül E., Özkök F., et al.
LETTERS IN DRUG DESIGN & DISCOVERY
, vol.22, no.5, 2025 (SCI-Expanded, Scopus)
2025
20257. In Vitro, Anti-Colon Cancer Activity of Green Dumbbell-Shaped Rhododendron luteum-Based Carbon Dots
Durmaz A., Mizan Kahyaoğlu İ., AYTAR E. C., DANIŞMAN KALINDEMİRTAŞ F., Sert E., Erol-Bozkurt A., et al.
CHEMISTRYOPEN
, vol.14, no.5, 2025 (SCI-Expanded, Scopus)
2025
20258. Improved apoptosis and mitochondrial dysfunction: the potential of carmofur-platinum nanoparticles.
Cilasun G. E., Özerkan D., Kariper I. A., Sert E., Korkut I. N., Kalındemirtaş F. D.
Biomedical materials (Bristol, England)
, 2025 (SCI-Expanded)
2025
20259. The Effect of T-Lymphocyte Subgroups at Diagnosis on The Prognosis of Chronic Lymphocytic Leukemia.
Seyithanoglu D., Sert E., Ozbalak M. M., Mastanzade M., Erdem S., Yenerel M. N.
Acta haematologica
, pp.1-11, 2025 (SCI-Expanded)
2025
202510. Dual-functionality of Hibiscus sabdariffa-CuO nanoparticles in chemotherapy and textile screen-printing on cellulose-based textiles
Tuzun E., EROL A., DANIŞMAN KALINDEMİRTAŞ F., Ozbas F., SERT E., Soomro R. A., et al.
CELLULOSE
, vol.32, no.4, pp.2471-2488, 2025 (SCI-Expanded, Scopus)
2025
202511. Machine Learning Regression for Assessing Sensing Performance and Anticancer Potential of Oolong Tea-Derived Silver Nanoparticles
SERT E., DANIŞMAN KALINDEMİRTAŞ F., Karakus E. E., EROL A., Ozbas F., Kucukdeniz T., et al.
JOURNAL OF THE ELECTROCHEMICAL SOCIETY
, vol.172, no.3, 2025 (SCI-Expanded, Scopus)
2024
202412. Potential multifaceted applications of cisplatin-loaded Camellia sinensis extract/CuO nanoparticles in cytotoxic and apoptotic effects
Danışman-Kalındemirtaş F., Sert E., TAN E., AKYÜZ E., KARAKUŞ S.
Biomass Conversion and Biorefinery
, vol.14, no.17, pp.20261-20273, 2024 (SCI-Expanded)
2024
202413. Enhancement of cytotoxic and apoptotic activity through oolong tea extract-mediated CuO/Cu2O nanoparticles
Karakuş E. E., Sert E., Erol A., Kalındemirtaş F. D., ÖZBAŞ F., KARAKUŞ S.
Journal of Drug Delivery Science and Technology
, vol.94, 2024 (SCI-Expanded)
2024
202414. Enhanced anticancer effect of newly synthesised albumin-bound Fe(III)-S-Methyl-thiosemicarbazones on breast cancer cells
Danisman-Kalindemirtas F., Erdem-Kuruca S., Cilasun G. E., SERT E., Ozerkan D., Demirci T. B., et al.
JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE
, vol.18, no.1, 2024 (SCI-Expanded)
2023
202315. CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
Seyithanoglu D., Nazligul E., Ozbalak M. M., Mastanzade M., Erdem S., Nalcaci M., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA
, vol.23, pp.319-320, 2023 (SCI-Expanded, Scopus)
2023
202316. The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
Seyithanoglu D., Nazligul E., ÖZBALAK M. M., MASTANZADE M., ERDEM S., NALÇACI M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, 2023 (SCI-Expanded)
2022
202217. The evaluation of anticancer activity by synthesizing 5FU loaded albumin nanoparticles by exposure to UV light
Kalındemirtaş F. D., KARİPER İ. A., Sert E., Okşak N., Kuruca S. E.
Toxicology in Vitro
, vol.84, 2022 (SCI-Expanded)
2022
202218. New oxovanadium(IV) complexes overcame drug resistance and increased in vitro cytotoxicity by an apoptotic pathway in breast cancer cells
DANIŞMAN KALINDEMİRTAŞ F., Kaya B., Sert E., ŞAHİN O., Kuruca S. E., ÜLKÜSEVEN B.
CHEMICO-BIOLOGICAL INTERACTIONS
, vol.363, 2022 (SCI-Expanded)
2022
202219. Evaluation of anticancer effects of carboplatin-gelatin nanoparticles in different sizes synthesized with newly self-assembly method by exposure to IR light
DANIŞMAN KALINDEMİRTAŞ F., KARİPER İ. A., Erdemir G., Sert E., Erdem-Kuruca S.
SCIENTIFIC REPORTS
, vol.12, no.1, 2022 (SCI-Expanded)
2022
202220. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia
Erkek E. T., Nazligul E., Nalcaci M., Yenerel M. N.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.38, no.2, pp.319-326, 2022 (SCI-Expanded)
2018
201821. Dramatic Reduction of LATS2 Tumor Suppressor Protein Expression in Patients with CLL: Evaluation of LATS2 Levels with Clinical Features and Immunophenotypic Profile
Sert E., Coskunpinar E., Yenerel M. N., Aktan M., Ozturk D., Ozturk O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.28, no.3, pp.137-146, 2018 (SCI-Expanded)
2013
201322. Leukemic ascites as an initial presentation of acute myelomonocytic leukemia with inversion of chromosome 16.
Yonal I., Kayar Y., Nazligul E., Yenerel M. N., Kalayoglu-Besisik S.
Annals of Saudi medicine
, vol.33, no.2, pp.197-8, 2013 (SCI-Expanded)
2012
201223. A case of chronic lymphocytic leukemia with massive ascites
Yonal I., Nazligul E., Tas G., Agan M. R., YENEREL M. N., NALÇACI M.
RARE TUMORS
, vol.4, no.4, pp.165-168, 2012 (ESCI)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. A novel compound heterozygous COL4A4 variant in a 24-year-old Alport syndrome case
Nazligul E., SUER İ., Kaya M., KALAYCI T., DİRİM A. B., ÇEFLE K., et al.
14. ULUSAL MOLEKÜLER BİYOLOJİ VE BİYOTEKNOLOJİ KONGRESİ, 1 - 02 November 2025, pp.124-130, (Full Text)
2025
20252. A novel compound heterozygous COL4A4 variant in a 24-year-old Alport syndrome case
Nazlıgül E., Suer İ., Kaya M., Kalaycı T., Dirim A. B., Çefle K., et al.
14. Ulusal Moleküler Biyoloji ve Biyoteknoloji Kongresi, Konya, Turkey, 1 - 02 November 2025, pp.124-130, (Full Text)
2015
20153. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria
Erkek E. T., Nazligul E., Nalcaci M., Aktan M., Yenerel M. N.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
Funded Projects
2024 - 2025
2024 - 2025Doksorubusin Yüklü Kiraz Sapı ve Hibiskus Özütünden Elde Edilen Nanopartiküllerin Sentezi Yapay Zeka Destekli Karakterizasyonu ve Antikanser Etkilerinin İncelenmesi
Project Supported by Higher Education Institutions , BAP Research Project
NAZLIGÜL E. (Executive), KALINDEMİRTAŞ DANIŞMAN F., KARAKUŞ S., ÖZEN EROĞLU G., ERDEMİR CİLASUN G.